For example, the increased expression of ATOX1 and MADCAM1 in MDA-MB-231 breast cancer cells corresponded with their promoter hypomethylation in canine DCIS and invasive cancer samples. This evidence concerns the gene MADCAM1 and ductal breast carcinoma in situ.